James Carthew: Smithson and GSCT look sensible options
Investors might be shunning small companies in favour of liquid mega caps but two global smaller cap trusts have been quietley delivering decent returns in the past year.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Investors might be shunning small companies in favour of liquid mega caps but two global smaller cap trusts have been quietley delivering decent returns in the past year.
Investors might be shunning small caps in favour of liquid mega caps but two global smaller companies trusts have been delivering decent returns.
Nick Price and Chris Tennant have bet on Mexico and Brazil receiving an economic stimulus from US interest rate cuts, as they look to catch up with their global EM peers.
Tideway is a separate company from troubled Thames Water, says International Public Partnerships.
QuotedData's James Carthew brands sale of Civitas Social Housing at 27% discount 'extremely disappointing' and questions how many other unloved trusts might follow.
The derated trust trades at a 30.2% discount to NAV, which appears harsh given the strength of its balance sheet, healthy dividend cover and strong cash-generating portfolio.
Two Princess Private Equity directors step down the day before the AGM where shareholders expressed displeasure about the performance of the fund.
The board proposed a limit of 10% of net asset value to be invested in Indian companies close to IPO, according to annual results, in which the trust underperformed its benchmark.
Rising income from floating rate loans has allowed the infrastructure debt investor to return more to shareholders, who are nevertheless nursing hefty paper losses.
Smallest UK-listed renewables fund forced to slash dividend after operational issues at tornado-hit wind farm.
The life sciences investment trust is refocusing on later-stage assets after its investment in gene therapy company SwanBio was nearly halved in a difficult biotech market.
After poor performance last year brought five-year returns below the benchmark, China’s reopening and strong stock selection have resulted in the emerging markets trust rebounding ahead of a July 2024 continuation vote.
Developed by Moore-Wilson